Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Ghanchi, Najia Karim ^a   Ursing, Johan ^b   Beg, Mohammad A ^a   Veiga, Maria I ^b,c   Jafri, Sana ^a   Mårtensson, Andreas ^b,d  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF ALGARVE   (Portugal)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE RESISTANCE TRANSPORTER; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; CARRIER PROTEIN; CHLOROQUINE; MDR1 PROTEIN, PLASMODIUM FALCIPARUM; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD SAMPLING; GENE DOSAGE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; MUTATIONAL ANALYSIS; NONHUMAN; PAKISTAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ADULT; CHILD; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENE; GENETICS; MALE; MUTATION; PARASITOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; GENE DOSAGE; GENES, PROTOZOAN; HUMANS; MALARIA, FALCIPARUM; MALE; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PAKISTAN; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 79251536849     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-18     Document Type: Article

References (40)

1. Prevalence of human malaria infection in bordering areas of East Balochistan, adjoining with Punjab: Loralai and Musakhel. MI Yasinzai JK Kakarsulemankhel, J Pak Med Assoc 2009 59 132 135 19288935
2. Resistance of Plasmodium falciparum malaria to chloroquine is widespread in eastern Afghanistan. MA Rab TW Freeman N Durrani D de Poerck MW Rowland, (Pubitemid 32178731)
3. Prevalence of Plasmodium slide positivity among the children treated for malaria, Jhangara, Sindh. S Hozhabri S Akhtar MH Rahbar SP Luby, J Pak Med Assoc 2000 50 401 405 11191438
4. Epidemiology of cerebral malaria and its mortality. AB Durrani IU Durrani N Abbas M Jabeen, J Pak Med Assoc 1997 47 213 215 9339620 (Pubitemid 128775826)
5. Chloroquine resistance and Plasmodium falciparum in Punjab, Pakistan during 2000-2001. MS Rana A Tanveer, Southeast Asian J Trop Med Public Health 2004 35 288 291 15691126 (Pubitemid 39248703)
6. Chloroquine-resistant Plasmodium falciparum: now in Pakistani Punjab. E Fox AA Khaliq M Sarwar GT Strickland, Lancet 1985 1 1432 1435 10.1016/S0140-6736(85)91855-0 2861372 (Pubitemid 15057982)
7. Chloroquine resistance in Pakistan and the upsurge of falciparum malaria in Pakistani and Afghan refugee populations. I Shah M Rowland P Mehmood C Mujahid F Razique S Hewitt N Durrani, Ann Trop Med Parasitol 1997 91 591 602 10.1080/00034989760680 9425361 (Pubitemid 27434593)
8. Chloroquine-resistant malaria in Pakistan. DS Robinson M Hadley-Brown OA Ejele PS Robinson, Lancet 1984 2 987 10.1016/S0140-6736(84)91207-8 6149382 (Pubitemid 15201208)
9. World malaria report. WHO, 2008 http://whqlibdoc.who.int/publications/ 2008/9789241563697-eng.pdf
10. Resistance of falciparum malaria to chloroquine and sulfadoxine- pyrimethamine in Afghan refugee settlements in western Pakistan: surveys by the general health services using a simplified in vivo test. M Rowland N Durrani S Hewitt E Sondorp, Trop Med Int Health 1997 2 1049 1056 10.1046/j.1365-3156.1997. d01-185.x 9391507 (Pubitemid 27505238)
11. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. CV Plowe A Djimde M Bouare O Doumbo TE Wellems, Am J Trop Med Hyg 1995 52 565 568 7611566
12. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. F Mendez A Munoz G Carrasquilla D Jurado M Arevalo-Herrera JF Cortese CV Plowe, Am J Epidemiol 2002 156 230 238 10.1093/aje/kwf030 12142257 (Pubitemid 34811961)
13. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. CV Plowe JF Cortese A Djimde OC Nwanyanwu WM Watkins PA Winstanley JG Estrada-Franco RE Mollinedo JC Avila JL Cespedes D Carter OK Doumbo, J Infect Dis 1997 176 1590 1596 10.1086/514159 9395372 (Pubitemid 27518161)
14. Mechanisms of resistance of malaria parasites to antifolates. A Gregson CV Plowe, Pharmacol Rev 2005 57 117 145 10.1124/pr.57.1.4 15734729 (Pubitemid 40283971)
15. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. T Triglia P Wang PF Sims JE Hyde AF Cowman, EMBO J 1998 17 3807 3815 10.1093/emboj/17.14.3807 9669998 (Pubitemid 28333967)
16. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. DA Fidock T Nomura AK Talley RA Cooper SM Dzekunov MT Ferdig LM Ursos AB Sidhu B Naude KW Deitsch XZ Su JC Wootton PD Roepe TE Wellems, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
17. A molecular marker for chloroquine-resistant falciparum malaria. A Djimde OK Doumbo JF Cortese K Kayentao S Doumbo Y Diourte A Dicko XZ Su T Nomura DA Fidock TE Wellems CV Plowe D Coulibaly, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152 (Pubitemid 32108530)
18. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. C Sisowath I Petersen MI Veiga A Martensson Z Premji A Bjorkman DA Fidock JP Gil, J Infect Dis 2009 199 750 757 10.1086/596738 19210165
19. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. C Sisowath PE Ferreira LY Bustamante S Dahlstrom A Martensson A Bjorkman S Krishna JP Gil, Trop Med Int Health 2007 12 736 742 10.1111/j.1365-3156.2007.01843.x 17550470 (Pubitemid 46872790)
20. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. L Mwai SM Kiara A Abdirahman L Pole A Rippert A Diriye P Bull K Marsh S Borrmann A Nzila, Antimicrob Agents Chemother 2009 53 5069 5073 10.1128/AAC.00638-09 19770282
21. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. HA Babiker SJ Pringle A Abdel-Muhsin M Mackinnon P Hunt D Walliker, J Infect Dis 2001 183 1535 1538 10.1086/320195 11319692 (Pubitemid 32417707)
22. Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. J Ursing PE Kofoed A Rodrigues L Rombo JP Gil, Am J Trop Med Hyg 2007 76 844 848 17488902 (Pubitemid 351627666)
23. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. S Picot P Olliaro F de Monbrison AL Bienvenu RN Price P Ringwald, Malar J 2009 8 89 10.1186/1475-2875-8-89 19413906
24. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). C Sisowath J Stromberg A Martensson M Msellem C Obondo A Bjorkman JP Gil, J Infect Dis 2005 191 1014 1017 10.1086/427997 15717281 (Pubitemid 40349821)
25. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. MT Duraisingh C Roper D Walliker DC Warhurst, Mol Microbiol 2000 36 955 961 10.1046/j.1365-2958.2000.01914.x 10844681 (Pubitemid 30326539)
26. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. RN Price AC Uhlemann A Brockman R McGready E Ashley L Phaipun R Patel K Laing S Looareesuwan NJ White F Nosten S Krishna, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742 (Pubitemid 39036891)
27. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. WMA, 2004 http://www.wma.net/en/30publications/ 10policies/b3/17c.pdf
28. Rapid diagnostic tests for malaria parasites. A Moody, Clin Microbiol Rev 2002 15 66 78 10.1128/CMR.15.1.66-78.2002 11781267 (Pubitemid 34052582)
29. Multiplex PCR-RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum. MI Veiga PE Ferreira A Bjorkman JP Gil, Mol Cell Probes 2006 20 100 104 10.1016/j.mcp.2005.10.003 16460912 (Pubitemid 43343722)
30. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal. D Ndiaye JP Daily O Sarr O Ndir O Gaye S Mboup DF Wirth, Trop Med Int Health 2005 10 1176 1179 10.1111/j.1365-3156.2005.01506.x 16262743 (Pubitemid 41641196)
31. Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of Plasmodium falciparum in Iran. J Ursing S Zakeri JP Gil A Bjorkman, Acta Trop 2006 97 352 356 10.1016/j.actatropica.2006.01.002 16490179
32. Prevalence of the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India. S Vinayak S Biswas V Dev A Kumar MA Ansari YD Sharma, Acta Trop 2003 87 287 293 10.1016/S0001-706X(03) 00021-4 12826304 (Pubitemid 36776315)
33. Division of communicable disease control newsletter. WHO, 2005 6 1 4
34. Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan. L Khatoon FN Baliraine M Bonizzoni SA Malik G Yan, Am J Trop Med Hyg 2009 81 525 528 19706926
35. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. A Ahmed D Bararia S Vinayak M Yameen S Biswas V Dev A Kumar MA Ansari YD Sharma, Antimicrob Agents Chemother 2004 48 879 889 10.1128/AAC.48.3.879-889.2004 14982779 (Pubitemid 38280339)
36. Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran. S Zakeri M Afsharpad A Raeisi ND Djadid, Malar J 2007 6 148 10.1186/1475-2875-6-148 17999755
37. A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. S Nair JT Williams A Brockman L Paiphun M Mayxay PN Newton JP Guthmann FM Smithuis TT Hien NJ White F Nosten TJ Anderson, Mol Biol Evol 2003 20 1526 1536 10.1093/molbev/msg162 12832643 (Pubitemid 37082588)
38. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. C Roper R Pearce B Bredenkamp J Gumede C Drakeley F Mosha D Chandramohan B Sharp, Lancet 2003 361 1174 1181 10.1016/S0140-6736(03) 12951-0 12686039 (Pubitemid 36398386)
39. Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India. V Lumb MK Das N Singh V Dev Wajihullah YD Sharma, Antimicrob Agents Chemother 2009 53 5173 5180 10.1128/AAC.00045-09 19786603
40. Origins and spread of pfdhfr mutant alleles in Plasmodium falciparum. T Mita, Acta Trop 2009 114 166 170 10.1016/j.actatropica.2009.07.008 19607799